Prodocs Solutions IPO

Incorporated in March 2019, Prodocs Solutions Limited is engaged in the IT-enabled services (ITES/BPO) business, primarily operating in the non-voice BPO segment. The company is a diverse non-voice BPO, providing a wide spectrum of services ranging from Indexing Services, Title Services, e-Publishing, and other business services comprising finance and accounting and litigation support. The company offers offshore solutions tailored to meet the needs of the clientele based primarily in US and Australia. The company's workforce of over 1,000 employees is mainly located in Mumbai at its delivery facility. This infrastructure enables them to maintain operational excellence and efficiency while meeting their clients' evolving demands. The company is certified with ISO 9001:2015 for Quality Management; ISO 14001:2015 for Environment Management and ISO 27001:2022 for Information Security Management, ensuring that all the services comply with rigorous International Standards of excellence, reliability, and data protection. Services: Title Services: They provide title insurance and related information services essential for real estate and mortgage settlement processes in the United States and select international market. E-Publishing Services: They provide a range of services for all aspects of digital publishing. Indexing Services: provide indexing services to clients across the US, Australia, and the UK. They process a variety of forms, including: Traffic citations, Rebate coupons, and Medical forms. As of October 31, 2025, the Company employs 1011 individuals. It holds certifications in quality management (ISO 9001:2015), environmental management (ISO 14001:2015), and information security (ISO 27001:2022). Competitive Strengths: Integrated solutions across multiple domains Commitment to quality and compliance Global reach with diverse clientele Experience and expertise

Information on this page is for general awareness only and is not investment advice. Grey market premium (when shown) is unofficial and indicative. Always read the RHP/DRHP and consult a qualified adviser before investing.